ARCHIVES

Trial: Decitabine Improves Survival in Myeloid Leukemia

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Letters: Broder Response To Waxman Called Political Back-Pedaling

February 11, 1994

GAO Criticizes Eppley, NCI For ‘Deficiencies’ In Review, Monitoring, Management of Contract

February 24, 1978

In Brief: Moffitt Cancer Center Awarded Core Grant; Biotech Industry Honors Jeffords, Bliley

May 29, 1998

Neutron Therapy “Treatment Of Choice” In Salivary Gland Tumors – 100 Percent Complete Reponses

June 13, 1986

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

February 18, 2005

In Brief: NCAB Committee Worried About Requirements for Comprehensive Centers, To Meet Again

May 27, 1988